1. Home
  2. OGN vs HSAI Comparison

OGN vs HSAI Comparison

Compare OGN & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • HSAI
  • Stock Information
  • Founded
  • OGN 1923
  • HSAI 2014
  • Country
  • OGN United States
  • HSAI China
  • Employees
  • OGN N/A
  • HSAI N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • HSAI
  • Sector
  • OGN Health Care
  • HSAI
  • Exchange
  • OGN Nasdaq
  • HSAI Nasdaq
  • Market Cap
  • OGN 2.5B
  • HSAI 2.7B
  • IPO Year
  • OGN N/A
  • HSAI 2023
  • Fundamental
  • Price
  • OGN $9.21
  • HSAI $22.63
  • Analyst Decision
  • OGN Hold
  • HSAI Strong Buy
  • Analyst Count
  • OGN 4
  • HSAI 2
  • Target Price
  • OGN $18.00
  • HSAI $27.65
  • AVG Volume (30 Days)
  • OGN 4.4M
  • HSAI 3.0M
  • Earning Date
  • OGN 08-05-2025
  • HSAI 08-18-2025
  • Dividend Yield
  • OGN 0.87%
  • HSAI N/A
  • EPS Growth
  • OGN N/A
  • HSAI N/A
  • EPS
  • OGN 2.69
  • HSAI N/A
  • Revenue
  • OGN $6,281,000,000.00
  • HSAI $309,148,901.00
  • Revenue This Year
  • OGN N/A
  • HSAI $61.47
  • Revenue Next Year
  • OGN $1.02
  • HSAI $44.10
  • P/E Ratio
  • OGN $3.43
  • HSAI N/A
  • Revenue Growth
  • OGN N/A
  • HSAI 24.20
  • 52 Week Low
  • OGN $8.01
  • HSAI $3.52
  • 52 Week High
  • OGN $23.10
  • HSAI $24.65
  • Technical
  • Relative Strength Index (RSI)
  • OGN 43.79
  • HSAI 58.11
  • Support Level
  • OGN $8.32
  • HSAI $20.66
  • Resistance Level
  • OGN $10.31
  • HSAI $23.20
  • Average True Range (ATR)
  • OGN 0.46
  • HSAI 1.19
  • MACD
  • OGN -0.10
  • HSAI 0.13
  • Stochastic Oscillator
  • OGN 43.13
  • HSAI 89.25

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: